Press Releases

Veterinary Dermatology Drugs Market Size Worth Around USD 8.9 Bn by 2027

Share This Article

The global Veterinary Dermatology Drugs market size is expected to be worth around USD 8.9 billion by 2027 from USD 3.8 Billion in 2020, growing at a CAGR of 4.2% from 2021 to 2027. Increasing usage of ethyl alcohol as befoul is major factor driving growth of the ethanol market.

Download Free Sample Copy with TOC, Graphs & List of Figures @https://www.novaoneadvisor.com/report/sample/5694

Report Scope of the Veterinary Dermatology Drugs Market

Report Scope Details
Market Size USD 8.9 Billion by 2027
Growth Rate CAGR of 4.2% From 2021 to 2027
Base Year 2020
Forecast Period 2021 to 2027
Historic Data 2017 to 2020
Report coverage Growth Factors, Revenue Status, Competitive Landscape,  and Future Trends
Segments Covered Product Type, Mode of Administration, Animal Type, Indication
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Merial, Zoetis, Inc., Ceva Sante Animale,  Vetmedica,   Vetoquinol S.A.,  Virbac S.A. ,Bayer Animal Health, Elanco, Novartis Animal Health, SAVAVET, Toray Industries, AB Science.

Growth Factors:

Veterinary dermatology, also referred as pet skin care, involves diagnosis, treatment, and prevention of skin problems in animals. Dermatological disorders or skin disorders are the most common medical conditions seen in animals. The most common sign of a dermatological problem in animals are licking, biting, repeatedly shaking the head, and excessive scratching or chewing of fur and skin. Additional symptoms of skin problems include lumps, hair loss, dandruff, a foul odor from ears or skin, and change in the texture or color of pet’s fur or skin. Itching is commonly seen in companion animals; atopic dermatitis is the common cause of itching.

 Variations in clinical presentations such as the extent of lesions, genetic factors, secondary infections, stage of the disease, and weather conditions could complicate the exact diagnosis of the disease. Atopy is genetically determined predisposition to become allergic to airborne pollens such as grass, weeds, trees, mold, and house dust. In domestic pets such as cats and dogs, atopic dermatitis is the most common cause of biting, chewing, rubbing, or ear infections as well as other chronic infections.

Get your Customized Research Report@https://www.novaoneadvisor.com/report/customization/5694

Veterinary Dermatology Drugs Market: Prominent Regions

In terms of region, the global veterinary dermatology drugs market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global veterinary dermatology drugs market in 2020, followed by Europe and Asia Pacific. North America is projected to be a highly attractive market from 2021 to 2027. The high revenue from the region can be attributed to the increase in government and private funding and large volume of tests performed. North America is also home to several key players such as Idexx, VCA, and Thermo Fisher, which augments the market. The veterinary dermatology drugs market in Asia Pacific is expected to be driven by availability of veterinary dermatology drugs, vaccines, and medicated feed additives for the well-being of the rapidly increasing livestock animal population in the region

COVID-19 Impact on Veterinary Dermatology Drugs Sales

  • Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the Veterinary Dermatology Drugs market.
  • Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.
  • Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.
  • Against this backdrop, Nova one advisor’s study predicts gradual recovery for the Veterinary Dermatology Drugs market 2021 onwards. This trend will however continue through the course of the report’s assessment period

Download This Full Research Report (Single User License US$ 3500)@https://www.novaoneadvisor.com/report/checkout/5694

Recent report on the Veterinary Dermatology Drugs market, with the help of a comprehensive outlook, provides readers with an assessment of the global market landscape. This study on the Veterinary Dermatology Drugs market analyzes the scenario for the period of 2017 to 2027, wherein, 2021 is the base year and 2020 is historical data. This report enables readers to make important decisions with regard to their business, with the help of a wealth of Information enclosed in the study. The report also provides the compound annual growth rate (CAGR) of the global Veterinary Dermatology Drugs market for the forecast period of 2021–2027. This data can help readers interpret quantitative growth aspects of the global market during the forecast period. It presents a wealth of information on key market dynamics, including drivers, market trends, and challenges, as well as the structure of the global market across the globe.

The report analyzes the historical and present-day scenario of the global Veterinary Dermatology Drugs market to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the global market in order to identify opportunities for stakeholders.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the Veterinary Dermatology Drugs market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the market.

The report delves into the competition landscape of the global Veterinary Dermatology Drugs market. Key players operating in the market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the Veterinary Dermatology Drugs market that are profiled in this report.

Y-o-Y growth comparison, volume and revenue comparison, and market share comparison of various market segments are provided in the report. The Veterinary Dermatology Drugs market is analyzed at both regional and country levels.

Key Players:

This report provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the Veterinary Dermatology Drugs market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.

Some of the prominent players in the Veterinary Dermatology Drugs market include:

  • Merial, Zoetis, Inc.
  • Ceva Sante Animale
  • Vetmedica
  • IDEXX Laboratories
  • Vetoquinol S.A.
  • Virbac S.A.
  • Bayer Animal Health
  • Boehringer Ingelheim
  • Elanco
  • Novartis Animal Health
  • SAVAVET
  • Toray Industries
  • AB Science

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

Global Veterinary Dermatology Drugs Market: Segmentation

  • Veterinary Dermatology Drugs Market, by Product Type
    • Antifungal Drugs
    • Antibacterial Drugs
    • Antiparasitic Drugs
    • Others
  • Veterinary Dermatology Drugs Market, by Mode of Administration
    • Topical
    • Oral
    • Injectable
  • Veterinary Dermatology Drugs Market, by Animal Type
    • Large Animals
      • Equine
      • Bovine
      • Others
    • Small Animals
      • Cats
      • Dogs
      • Others
  • Veterinary Dermatology Drugs Market, by Indication
    • Infectious Diseases
    • Skin Cancer
    • Autoimmune Skin Diseases
    • Parasitic Infections
    • Others

 Research Methodology

A unique research methodology has been utilized to conduct a comprehensive research on the growth of the global Veterinary Dermatology Drugs market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.

These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global Veterinary Dermatology Drugs market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.

Key Questions are

  • What are the key factors influencing the Veterinary Dermatology Drugs market in each region?
  • How much value will the global market generate by the end of the forecast period?
  • What will be the CAGR of the global market between 2021 and 2027?
  • What would be the Y-o-Y growth trend of the global market between 2021 and 2027?
  • What is the future scope and current trends in technologies of the global market?
  • What is the revenue of the global market based on segments?
  • Which key strategies are used by top players of the global market?
  • Which are the leading companies in the global market?
  • What are the essential strategies by key stakeholders in the market to expand their geographic presence?
  • What are the major advancements witnessed in the global market?

Why should you invest in this report?

If you are aiming to enter the global Veterinary Dermatology Drugs market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for Veterinary Dermatology Drugs are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2027 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

`Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global  Veterinary Dermatology Drugs Market, By Product Type

7.1.   Veterinary Dermatology Drugs  Market, by Product Type, 2021-2027

7.1.1.     Antifungal Drugs

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Antibacterial Drugs

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Antiparasitic Drugs

7.1.3.1.          Market Revenue and Forecast (2016-2027)

7.1.4.     Others

7.1.4.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global  Veterinary Dermatology Drugs Market, By Mode of Administration

8.1.   Veterinary Dermatology Drugs  Market, by Mode of Administration, 2021-2027

8.1.1.     Topical

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Oral

8.1.2.1.          Market Revenue and Forecast (2016-2027)

8.1.3.     Injectable

8.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global  Veterinary Dermatology Drugs Market, By Animal Type

9.1.   Veterinary Dermatology Drugs  Market, by Animal Type, 2021-2027

9.1.1.     Large Animals

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     Small Animals

9.1.2.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global  Veterinary Dermatology Drugs Market, By Indication

10.1.           Veterinary Dermatology Drugs  Market, by Indication, 2021-2027

10.1.1.  Infectious Diseases

10.1.1.1.       Market Revenue and Forecast (2016-2027)

10.1.2.  Skin Cancer

10.1.2.1.       Market Revenue and Forecast (2016-2027)

10.1.3.  Skin Cancer

10.1.3.1.       Market Revenue and Forecast (2016-2027)

10.1.4.  Parasitic Infections

10.1.4.1.       Market Revenue and Forecast (2016-2027)

10.1.5.  Others

10.1.5.1.       Market Revenue and Forecast (2016-2027)

Chapter 11.Global  Veterinary Dermatology Drugs  Market, Regional Estimates and Trend Forecast

11.1.          North America

11.1.1.  Market Revenue and Forecast, by Product Type (2016-2027)

11.1.2.  Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.1.3.  Market Revenue and Forecast, by Animal Type (2016-2027)

11.1.4.  Market Revenue and Forecast, by Indication (2016-2027)

11.1.5.  U.S.

11.1.5.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.1.5.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.1.5.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.1.5.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.1.6.  Rest of North America

11.1.6.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.1.6.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.1.6.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.1.6.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.2.          Europe

11.2.1.  Market Revenue and Forecast, by Product Type (2016-2027)

11.2.2.  Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.2.3.  Market Revenue and Forecast, by Animal Type (2016-2027)

11.2.4.  Market Revenue and Forecast, by Indication (2016-2027)

11.2.5.  UK

11.2.5.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.2.5.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.2.5.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.2.5.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.2.6.  Germany

11.2.6.1.       Market Revenue and Forecast, by Product Type(2016-2027)

11.2.6.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.2.6.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.2.6.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.2.7.  France

11.2.7.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.2.7.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.2.7.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.2.7.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.2.8.  Rest of Europe

11.2.8.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.2.8.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.2.8.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.2.8.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.3.          APAC

11.3.1.  Market Revenue and Forecast, by Product Type (2016-2027)

11.3.2.  Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.3.3.  Market Revenue and Forecast, by Animal Type (2016-2027)

11.3.4.  Market Revenue and Forecast, by Indication (2016-2027)

11.3.5.  India

11.3.5.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.3.5.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.3.5.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.3.5.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.3.6.  China

11.3.6.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.3.6.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.3.6.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.3.6.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.3.7.  Japan

11.3.7.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.3.7.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.3.7.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.3.7.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.3.8.  Rest of APAC

11.3.8.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.3.8.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.3.8.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.3.8.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.4.          MEA

11.4.1.  Market Revenue and Forecast, by Product Type (2016-2027)

11.4.2.  Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.4.3.  Market Revenue and Forecast, by Animal Type (2016-2027)

11.4.4.  Market Revenue and Forecast, by Indication (2016-2027)

11.4.5.  GCC

11.4.5.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.4.5.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.4.5.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.4.5.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.4.6.  North Africa

11.4.6.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.4.6.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.4.6.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.4.6.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.4.7.  South Africa

11.4.7.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.4.7.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.4.7.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.4.7.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.4.8.  Rest of MEA

11.4.8.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.4.8.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.4.8.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.4.8.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.5.          Latin America

11.5.1.  Market Revenue and Forecast, by Product Type (2016-2027)

11.5.2.  Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.5.3.  Market Revenue and Forecast, by Animal Type (2016-2027)

11.5.4.  Market Revenue and Forecast, by Indication (2016-2027)

11.5.5.  Brazil

11.5.5.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.5.5.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.5.5.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.5.5.4.       Market Revenue and Forecast, by Indication (2016-2027)

11.5.6.  Rest of LATAM

11.5.6.1.       Market Revenue and Forecast, by Product Type (2016-2027)

11.5.6.2.       Market Revenue and Forecast, by Mode of Administration (2016-2027)

11.5.6.3.       Market Revenue and Forecast, by Animal Type (2016-2027)

11.5.6.4.       Market Revenue and Forecast, by Indication (2016-2027)

Chapter 12.   Company Profiles

12.1.                 Merial, Zoetis, Inc

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.                 Ceva Sante Animale

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.                 Vetmedica

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.                 Vetoquinol S.A

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.                 IDEXX Laboratories

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.                 Toray Industries

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.                 Bayer Animal Health

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.                 Elanco

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.                 Novartis Animal Health

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.              SAVAVET

12.10.1.                   Company Overview

12.10.2.                   Product Offerings

12.10.3.                   Financial Performance

12.10.4.                   Recent Initiatives

Chapter 13.   Research Methodology

13.1.                 Primary Research

13.2.                 Secondary Research

13.3.                 Assumptions

Chapter 14.   Appendix

14.1.                 About Us

14.2.                 Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 3500)@https://www.novaoneadvisor.com/report/checkout/5694

About Us

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@novaoneadvisor.com

Show More

Steve Robber

My name is Steve Robber, I’m the Owner of Market Stats News. Steve has served in many positions at various organizations for the past seven years. Currently he is an Author at Finance.Yahoo. Contact us for a free news publication, we look forward to speaking with you!

Related Articles

Back to top button